Cannabis stocks news - daily news on stocks on CSE, TSX, TSXV, OTC, NASDAQ and NYSE from InvestorIdeas.com
Tuesday 23 June 2020
Monday 22 June 2020
Investorideas.com - Health and Wellness Stock News: Neptune's (NASDAQ: $NEPT) (TSX: $NEPT.TO) New Natural, Plant-Based Hand Sanitizers to Launch in Club Store Channel
Investorideas.com - Health and Wellness Stock News: Neptune's (NASDAQ: $NEPT) (TSX: $NEPT.TO) New Natural, Plant-Based Hand Sanitizers to Launch in Club Store Channel
Join our Investor Club https://www.investorideas.com/membership/
Join our Investor Club https://www.investorideas.com/membership/
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 432 (CSE: $LIB.C) (NASDAQ: $NEPT) (TSX: $NEPT.TO) (TSXV: $N.V) (CSE: $BILZ.C) (NYSE: $IFF) (TSXV: $NRTH.V) (TSX: $AVCN.TO)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 432 (CSE: $LIB.C) (NASDAQ: $NEPT) (TSX: $NEPT.TO) (TSXV: $N.V) (CSE: $BILZ.C) (NYSE: $IFF) (TSXV: $NRTH.V) (TSX: $AVCN.TO)
Delta, Kelowna, BC, June 22, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/06221LIB-NEPT-N-BILZ-IFF-NRTH-AVCN.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Liberty
Leaf Holdings Ltd. (CSE:
LIB)(OTC:
LIBFF) announced that it
has entered into an agreement with Nova Mentis Biotech Corp., pursuant to which
LIB will acquire, by way of share exchange, 100 per cent of all of the issued
and outstanding securities of NOVA.
Highlights of the Transaction:
● LIB
gains NOVA's current net cash balance of approximately $1.2M CDN;
● Adds
synergistic accompaniment to LIB's operating and licensed cannabis assets
within the health and wellness sector;
● Bolsters
roster of personnel who possess experience within scientific and R&D
community; and
● Provides
opportunity for intellectual property creation as NOVA advances its research
mandate.
NOVA is a research and development
driven company that is focused on investigating the anti-inflammatory effects
of psilocybin in underexplored metabolic indications such as obesity and
diabetes. NOVA is of the view that its
target indications represent vast and growing segments of the population. For example, in the United States, more than
10.5% of the population has Diabetes, which represents approximately 34.2
million people. Diabetes treatment can
bare significant economic burden to patients with the average out of pocket
monthly cost being estimated at $360 USD.
According to a report by Fortune Business Insights, the global diabetes
drug market size was valued at USD $48 Billion in 2018 and is projected to
reach USD $78 Billion by 2026.
Increasing societal prevalence of sedentary lifestyles coupled with vast
access to inexpensive and nutritionally void food options are likely to
contribute to further incidence of obesity and diabetes in the future. According to the National Center for Health
Statistics, 39.8% of the US population aged 20 and over were considered obese
in 2016, with an additional 31.8% being considered overweight. Obese individuals have a significantly higher
incidence of depression (close to 30%) compared to the general population.
Bidirectionally, according to the CDC, about 43% of depressed people are obese.
The strong therapeutic potential of
psilocybin has emerged for a wide range of disorders, primarily mental health
related. NOVA is focusing on a cohort group that has been very difficult to
treat, both acutely and also in a sustainable way. This group of individuals
have an overlap in two widespread and very important indications, obesity and
depression. These comorbid conditions share inflammation as an important common
mediator. NOVA's pre-clinical scientific study thus far is focused on targeting
the gut-brain axis to modulate inflammation in this context. The aim is to
utilize the unique properties of psilocybin to address both physiological and
behavioural factors in obesity and comorbid depression.
NOVA was founded and is led by Dr.
Aylia Mohammadi. Dr. Mohammadi obtained her PhD in Biological Physics from the
Donnelly Centre for Cellular & Biomolecular Research at the University of
Toronto, and subsequently completed a postdoctoral fellowship at the
Lunenfeld-Tanenbaum Research
Institute at Mount Sinai Hospital in Toronto. Aylia is a TEDx speaker, and has
presented her work at international conferences. Her graduate training was
inherently multidisciplinary, integrating techniques in molecular biology,
neuroscience, and genetics. For her postdoctoral research, she examined
underlying molecular mechanisms of inflammatory bowel disease, giving her a
strong and relevant background to guide NOVA's scientific aims.
"Recent scientific advancement
coupled with shifting opinions amongst, both the medical and general
communities, at large regarding psychedelics including psilocybin make it a
sector worthy of investment," stated Will Rascan, President and CEO of
LIB. "Since our shift into cannabis
in 2014, and our subsequent investment in Just Kush Enterprises Ltd, - now a
holder of three Health Canada Cannabis Licenses – we have focused on emerging
trends and shifting public awareness of natural based compounds for health and
wellness, I believe this acquisition compliments our current legal cannabis
portfolio and provides stakeholders with an early entrance in a new flourishing
market."
Neptune
Wellness Solutions Inc. (NASDAQ:
NEPT) (TSX:
NEPT), a diversified and fully integrated health and
wellness company, announced today
an expansion of its branded hand sanitizer product line.
Developed by Neptune Health &
Wellness Innovations, in partnership with International
Flavors & Fragrances (NYSE:
IFF),
the expanded product line consists of six new scented varieties, including
Garden Mint, Fresh Linen, Orange Hibiscus, Eucalyptus, Fresh Lemon & Tea
Tree, and Lavender. Neptune's products are natural, plant-based sanitizers made
with a specialized blend of essential oils, aloe vera and fruit extract.
The expanded hand sanitizer product
line is expected to launch in July in the club store channel through one of the
largest retailers in the world. Neptune's partnership with IFF allows for rapid
product development and delivery to retailers to ensure products are on the
shelf and available to consumers. The
Company expects expanded hand sanitizer revenues to be realized beginning in
the second quarter of fiscal year 2021.
"We believe natural,
plant-based products are the future as consumers pay increased attention to
their health and wellness and use hand sanitizer products more frequently to
prevent the spread of germs and bacteria," said Michael Cammarata, Chief
Executive Officer of Neptune Wellness Solutions. "The expansion of our hand sanitizer
product line through our partnership with IFF offers consumers a better
experience with a variety of great scents, as well as essential oils and aloe
vera to promote skin health. We look
forward to increasing our distribution nationwide through our retail
partnerships."
Nicolas Mirzayantz, IFF Divisional
CEO, Scent, said, "We are proud to partner with Michael and his team on
this timely and important product line.
It is exciting to bring the talents of our perfumers and IFF's
exceptional portfolio of natural and sustainable ingredients to create
fragrances that help make keeping safe a better experience for consumers."
Neptune Health & Wellness
Innovations is rapidly bringing new products to market to address market demand
for critical health and wellness products such as the Neptune Halo oximeter,
the Neptune Air non-contact thermometer, as well as hand sanitizer products and
other innovations in development.
Namaste
Technologies Inc. (TSXV:
N)
(OTC:
NXTTF), a leading platform for cannabis products,
accessories, and education, today
announced CannMart Inc., a wholly owned subsidiary,
has been granted an exclusive license by IGNITE
International Brands, Ltd. (CSE:
BILZ) (OTCQX:
BILZF) to utilize certain brand trademarks on cannabis-based
products for sale in the legal Canadian marketplace. In addition, CannMart has
received approval from Alberta Gaming, Liquor & Cannabis and the Ontario
Cannabis Retail Corporation operating as the Ontario Cannabis Store to begin
offering Cannabis 2.0 products.
"Our agreement to become the
exclusive distributor of IGNITE products in Canada is an important milestone
for the company and positively reflects on our value proposition," said
Meni Morim, CEO of Namaste Technologies. "CannMart continues to
demonstrate its ability to grow its sales distribution channels in the Canadian
market and this is attracting the attention of well-established brands like
IGNITE. We place a high value on our relationships with these brands as it is
our belief that brand recognition will be a major driver of growth as the legal
industry matures and transitions to consumer-packaged goods. The opportunity
for CannMart to be the exclusive distributor for IGNITE in Canada reinforces
our position in the competitive cannabis market as consumers gravitate towards
brands that are well known and trusted for their quality."
"The listing of Cannabis 2.0
products for the provinces of Ontario and Alberta is an important achievement
and opens meaningful additional revenue channels. The Cannabis 2.0 market is a
large addressable market and the approval to list our products in Alberta and
Ontario, with more than 450 and 90 cannabis stores respectively, represents a
substantial increase in the addressable market for CannMart. We expect to
continue our recent sales success of cannabis products from premium brands,
like IGNITE, through CannMart.com and throughout our network of government
partners and retailers."
"Canada is an important market
for IGNITE International Brands and CannMart has shown its ability to deliver
high quality products to our target market," said Lester Lee, President of
IGNITE. "The awareness of the IGNITE brand continues to build throughout
Canada and our product sales continue to grow. The team at CannMart has been
instrumental and has proven their competency to navigate the regulations within
the legal market. We trust that our brand can be nurtured in accordance with
our high standards and together we can continue to build on our early success
as we look to grow market share."
Further to the news release of March
20, 2020, CannMart and IGNITE have amended the licensing agreement to add
exclusivity to the markets in Canada. The revised agreement grants CannMart an
exclusive licence to use certain IGNITE brand trademarks on legal cannabis-based
products (the "IGNITE Products") in consideration for certain royalty
payments. CannMart's introduction of IGNITE cannabis products has been welcomed
by its customers and demand has continued to grow.
CannMart's listing of its first
Cannabis 2.0 products in the provinces of Alberta and Ontario are now approved
by both jurisdictions. CannMart's first offering will be a variety of vape
cartridges. The AGLC is responsible for regulating and distributing cannabis to
Alberta's licensed retailers and the sole legal online retailer for
recreational cannabis at www.albertacannabis.org. The
OCS is the sole legal online retailer and wholesaler for recreational cannabis
for Canada's most populous province.
48North
Cannabis Corp. (TSXV:
NRTH) reported a
successful first week of planting on Good:Farm, one of Canada's first and
largest outdoor cannabis facilities.
Following the first season for
licensed outdoor cultivation in Canada, 48North enters the upcoming season with
improved know how, as well as operational and structural improvements to ensure
that Good:Farm helps meet the steady demand for 48North products and positions
itself to take advantage of opportunities for contract manufacturing
partnerships.
"48North's commitment to
cultivating outdoor, organic, sun-grown cannabis positions us to deliver the
products our customers deserve in 2020," said Charles Vennat, CEO of
48North. "Without question, outdoor cultivation has been a game changer
for the industry in terms of cost and quality. Last year, the Company learned
important operational lessons in our season that will inform our 2020 approach.
Our early mover advantage positions us to thrive in this space, while
continuing to drive down cultivation costs below last year's benchmark of $0.25
per gram."
48North has taken the planting
"off season" to focus on critical operational improvements at
Good:Farm, including:
● Construction
of a state-of-the-art drying facility on site, purpose built to be adapted for
indoor cultivation in the winter (48North's licence amendment application was
submitted for the drying facility on May 8th and early conversations with
Health Canada leave the Company confident in its ability to receive approval in
time for harvest);
● Leveraging
genetics that succeeded outdoors in the first season at Good:Farm, through an
in-house genetic breeding program,
● Introducing
clone and tissue culture cultivation to Good:Farm, in addition to the Company's
experience with seed stock;
● Expanding
beyond Good:Farm's organic farming processes, with a specific focus on
regenerative practices to nurture more resilient soils for nutrient-rich crops,
this includes the consideration of the longevity and fertility of our farm;
● Recruiting
new management with local know how and successful outdoor cannabis cultivation
experience; and
● Emphasizing
the Company's commitment to sustainability by eliminating single-use plastics
in the production process.
Good:Farm's inaugural planting
season demonstrated that high-quality, low cost cannabis for next generation
cannabis products is best grown on a farm. Popular strains and products already
on the market are the result of 48North's first harvest. The Company's added
experience and operational upgrades will position it to build on this momentum
and deliver on its initial vision of giving people the latitude to live well
through high-quality cannabis products.
Avicanna
Inc. (TSX:
AVCN) (OTCQX:
AVCNF), a biopharmaceutical company focused on the
development, manufacturing and commercialization of plant-derived
cannabinoid-based products, announced that on
July 21st, 2020 it will be hosting a virtual symposium titled "Medical
Cannabis 2.0" in partnership with Medical Cannabis by Shoppers. Patients
and health care practitioners globally can join the virtual symposium to learn
more about the potential advantages of medical cannabis and the advancement of
product offerings including Avicanna's RHO Phyto product offerings and advanced
cannabinoid research collaboration at the University of Toronto. In addition,
experts will discuss the pharmacology, safety, and dosing guidelines of medical
cannabis for therapeutic conditions.
This includes presentations on the, efficacy of cannabinoids for chronic
pain, anxiety, depression, and other comorbidities as well as an overview of
the patient pathway to Medical Cannabis by Shoppers.
"In this unprecedent time,
where patients and practitioners have many questions and are seeking
alternative and natural solutions, we are pleased to welcome you all to our
virtual symposium on medical cannabis. My talk on Common Medical Comorbidities
will discuss how medical cannabis can be used for the management of clinical conditions
that have common associated comorbidities of anxiety, depression and appetite
and sleep disorders. Alongside my colleagues and collaborators, we hope you
will find value in all our presentations and that they will provide important
information, as patients and health care practitioners seeking to learn more
about medical cannabis." – Dr. Amza Ali, Chief Medical Officer of Avicanna
Discussions will be led by
clinicians and scientists from the Avicanna team as well as from prestigious
Canadian academic and clinical research organizations including the University
of Toronto and University Health Network's Toronto General Hospital.
The agenda for the virtual symposium
is as follows:
● An
Introduction to Cannabinoids and Their Pharmacology – Dr. Ruth Ross (Professor
and Chair, Department of Pharmacology & Toxicology, Faculty of Medicine,
University of Toronto, Senior Scientist, Campbell Family Mental Health Research
Institute, CAMH)
● Advanced
Cannabinoid Research and drug development at the University of Toronto – Dr.
Pauric Bannigan (Post-Doctoral Fellow from Dr Christine Allen's laboratory at
the Leslie Dan Faculty of Pharmacy, University of Toronto)
● Medical
Cannabis 2.0 and Avicanna's RHO Phyto product offerings– Dr. Justin Grant
(Executive Vice President of Scientific Affairs, Avicanna)
● The
Potential of Cannabinoids for Chronic Pain – Dr. Hance Clarke (Staff
Anesthesiologist
Director Pain Services, Director Good Hope Ehlers Danlos Clinic, Medical Director of The Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Associate Professor, Department of Anesthesia, University of Toronto)
Director Pain Services, Director Good Hope Ehlers Danlos Clinic, Medical Director of The Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Associate Professor, Department of Anesthesia, University of Toronto)
● Anxiety,
Depression and Other Comorbidities in Patients to be Treated with Cannabinoids:
Implications for Optimal Care – Dr. Amza Ali (Chief Medical Officer, Avicanna)
● An
Introduction to Medical Cannabis by Shoppers Drug Mart – Neil D'Souza (Senior
Manager, Operations, Medical Cannabis by Shoppers Drug Mart)
● The
Future of Medical Cannabis Panel Discussion– (Aras Azadian, CEO of Avicanna
Inc. / Pat McCutcheon, CEO MediPharm Labs / Kaveh Kahen, CEO of Sigma
Analytics)
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
#Cannabis /#CBD #Stock News: American Green's (OTC: $ERBB) Smart Vending Machine called the "AGM"- Part of Growth Trend for Vending Machines During Pandemic; @American__Green
#Cannabis /#CBD #Stock News: American Green's (OTC:
$ERBB) Smart Vending Machine called the "AGM"- Part of Growth Trend
for Vending Machines During Pandemic; @American__Green
PHOENIX,
AZ, June 22, 2020 (Investorideas.com newswire) – Breaking cannabis/CBD stock and
sports news: American Green (OTC:ERBB) reported last
month that EZ WEED has selected and purchased the company’s proprietary
smart vending solution -- called the “AGM” -- as their “system of choice”
for EZ Weed’s new business venture teaming up with prospective
cannabis dispensaries throughout the nation.
Read this news
featuring ERBB in full at https://www.investorideas.com/news/2020/cannabis/06221OTCERBB-SmartVendingMachine-AGM.asp
ERBB:Lindel
Creed of American Green (OTC: $ERBB) chats with retired NFL
Linebacker-turned-venture-capitalist Lamarr Houston and Lauren Smee of EZ Weed
when visiting American Green's vending machine facility in Gastonia, NC.
According
to recent news since their
selection they are right on the money: “Reasons Why Vending Machines Are
Gaining in Popularity- No Social Contact”
“With
the current pandemic around the world, people prefer to purchase drinks and
snacks from a machine, as it eliminates the need for human contact, which is
one reason for the increased interest in vending machines.”
EZ
Weed is run by Managing Partner, Lauren Smee and backed by retired NFL
Linebacker-turned-venture-capitalist, Lamarr Houston. Mr. Houston, who
played professionally for the Oakland Raiders and Chicago Bears, recently
visited American Green’s AGM facility in Gastonia, NC. According to
AGM Division Head, Lindel Creed, “It was obvious to me from the minute they
both arrived at the AGM facility, that both Ms. Smee and Mr. Houston knew
exactly which machine features they required for their venture and, by the time
they left the facility, both were convinced that American Green could provide
them.”
EZ
WEED expects to purchase and supply the AGM Dispensing Vending Machines
following their up-and-coming EZ Weed national launch and have already begun
securing their location agreements with some of the top dispensaries in the
US. According to Ms. Smee, “Our partnership with American Green is vital
in reaching our goal of becoming the first national and mainstream marijuana
vending machine provider and service. The automation, humanless sales method,
and intelligent vending capabilities of the AGM will allow us to scale for high
growth.”
EZ
WEED was founded in January 2020. The company came to fruition organically
through a love of cannabis and Ms. Smee’s extensive knowledge in launching
startups -- with a new twist and groundbreaking sales method in the cannabis
industry. The average sales process in a dispensary can be anywhere from
15-45 minutes. With EZ WEED, the entire process, even as a first-time user, is
on average 3 to 5 minutes.
Besides
the state-of-the-art machines, EZ WEED also provides its dispensary partners
with “white glove” customer service as well as completely customizable digital
marketing for each American Green AGM vending machine it provides. We do all
the work pertaining to custom menus, product display, machine maintenance and a
dedicated account manager that remotely keeps track of machine sales and
inventory.
According
to EZ Weed, serving cannabis users in an efficient manner has proven to be a
challenge on a national level. With forward-thinking ideas and the
backing of the venture capital firm, League Ventures, EZ
WEED stands
ready to enhance the sales process for new and seasoned cannabis users all
across America. Please visit the websites of these two great companies by
clicking on their names above.
American
Green looks forward to a great long-term relationship with EZ WEED and believes
that their expedient, reduced-human interaction is perfect for our country’s
environment for today and years to come.
If
you are an experienced vending route operator serving a major market and wish
to add a complete line of fully legal CBD products to your existing route, you
should contact Mr. Lindel Creed at American Green’s AGM Vending Division
located in Gastonia, North Carolina. You can email Lindel
at lindel@americangreen.com or call him on his direct line at
704-718-3158.
Shareholders
and interest holders may also stay current with American Green Updates:
Twitter:
@American__Green (two underscores), or
About American
Green, Inc.
American
Green, Inc. became, in 2009, America’s second publicly-traded company in
the cannabis industry. American Green now, with its more than 50,000 individual
certified shareholders, is one of the largest (in shareholder count) in the
cannabis sector. American Green's mission is to lead the cannabis and
premium CBD industry. Leveraging our team of professionals in cultivation
management, manufacturing, extraction, wholesale, retail, and community
outreach, we strive to develop sustainable initiatives in the cannabis-adjacent
and CBD industries, laser-focused on adding company and shareholder value.
For more
information -
Contact:
American
Green, Inc.
Investor
Relations
2902
W. Virginia Ave
Phoenix,
AZ 85009
480-443-1600
X555
NOTES ABOUT
FORWARD-LOOKING STATEMENTS
Except
for any historical information contained herein, the matters discussed in this
press release contain forward-looking statements that involve risks and
uncertainties, including those described in the Company's Securities and
Exchange Commission reports and filings. Certain statements contained in this
release that are not historical facts constitute forward-looking statements,
within the meaning of the Private Securities Litigation Reform Act of 1995, and
are intended to be covered by the safe harbors created by that Act. Reliance
should not be placed on forward-looking statements because they involve unknown
risks, uncertainties and other factors, which may cause actual results,
performance or achievements to differ materially from those expressed or
implied. Forward-looking statements may be identified by words such as
estimates, anticipates, projects, plans, expects, intends, believes, be should
and similar expressions and by the context in which they are used. Such
statements are based upon current expectations of the Company and speak only as
of the date made. The Company undertakes no obligation to update any
forward-looking statements to reflect events or circumstances after the date on
which they are made.
Paid news
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure : this news release
featuring American Green (ERBB:OTC) is a paid for news release on
Investorideas.com https://www.investorideas.com/News-Upload/
More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
About
Investorideas.com
Sign
up for free stock news alerts at Investorideas.com
Friday 19 June 2020
Investorideas.com - Campaign to Legalize, Regulate, and Tax Adult Use Marijuana in Montana Submits Signatures for November Ballot
Investorideas.com - Campaign to Legalize, Regulate, and Tax Adult Use Marijuana in Montana Submits Signatures for November Ballot
Join our Investor Club https://www.investorideas.com/membership/
Join our Investor Club https://www.investorideas.com/membership/
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 431 (CSE: $DOSE.C) (OTCQB: $ALID) (CSE: $LHS.C) (CSE: $THC.C)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 431 (CSE: $DOSE.C)
(OTCQB: $ALID) (CSE: $LHS.C) (CSE: $THC.C)
Delta, Kelowna, BC, June 19, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/06191DOSE-ALID-LHS-THC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Rapid
Dose Therapeutics Corp. (CSE:
DOSE), a Canadian Life Sciences company focused on innovative
drug and active ingredient delivery solutions, announced that it
has filed a non-provisional patent with the USPTO for an “Apparatus for and method of converting cbd and/or cbd derivatives to at
least one other type of cannabinoid and/or cannabinoid derivative such as THC”.
In conjunction with McMaster University and the team lead by Dr. James McNulty,
RDT has discovered a new and efficient way to create THC from CBD. This
selective method can generate delta 8 or
delta 9 THC.
Jason Lewis, RDT SVP and co-inventor
said, “This is an incredible breakthrough for RDT and the industry as a whole.
Our technology could revolutionize the way synthetic THC is created so patients
around the world can have access to a consistent quality of delta 8 or delta 9.
Instead of the industry being dependent on the many complicated variables
associated with growing cannabis and the expense of cultivating indoors, we
created a method to convert hemp-derived CBD to THC. This is the innovation
required to allow pharmaceutical companies to embrace cannabinoid treatments.”
“This process is novel and highly
efficient at selectively converting CBD isolate or distillate into synthetic
THC,” said Dr. McNulty. “Our
collaboration with RDT has resulted in a transformative outcome that we are
proud to be involved with. There are numerous
high yield derivatives we can control for using naturally derived CBD through
the innovative conversion. My team is excited about the possibilities to
provide pure cannabinoids for life science companies.”
The PCT application is a follow up
to the RDT provisional patent filed on April 5, 2019. Mark Upsdell, RDT CEO, said: “Despite the
current COVID situation creating delays around the globe, RDT remains committed
to research and innovation. Our filing
of this patent is an indication that our continued work with McMaster is
aligned with our overall strategy to create unique products aimed at improving
patient outcomes. The ability to combine
this innovation with our unique QuickStrip™ delivery system will create new
opportunities for RDT.”
Allied
Corp.
(OTCQB:
ALID), an international medical cannabis company focused on
creating and providing targeted cannabinoid health solutions to address today’s
medical issues is pleased to announce the initiation of a pharmaceutical human
clinical PHASE I research trial with MGC
Pharmaceuticals.
Under the terms of this agreement,
MGC Pharma will provide a comprehensive suite of pharmaceutical services to
advance Allied’s pharmaceutical products into human clinical PHASE 1. This
trial will test the efficacy and pharmacodynamics of Allied’s pipeline of
proprietary cannabis derived drug candidates targeting Post Traumatic Stress
Disorder (PTSD). The scope of MGC
Pharma’s services will cover clinical research, IMP registration, manufacturing
of lab volumes for the research project, drug stability testing, GMP
manufacturing and regulatory assistance for obtaining an Investigational
Medicinal Product (IMP) number that is needed in order to sell the
pharmaceutical product.
Allied has also conducted an
extensive prior art review on its previously submitted provisional patents for
products AC001 and AC002 and has decided to abandon these. Along with creation
of new formulations, representing the conception of new inventions, and its
prior art review, Allied will submit patent submissions for products ALID-10
and ALID-11. ALID-10 and ALID-11 will be the products entering into the human
clinical trials.
“This agreement with MGC Pharma is a
significant milestone for Allied as we continue to make progress towards
advancing our first cannabis derived pharmaceutical product into clinical
trials for PTSD”, said Calum Hughes, CEO of Allied. “The drug candidates to be developed in our
collaboration with MGC Pharma have been validated by Allied’s research through
preliminary case study evidence conducted by our corporate physician and the
Allied team. We are excited to be working with MGC Pharma, a company with a
proven track record in developing cannabis-based drugs and bringing them to
market. We look forward to leveraging
their technical capabilities to accelerate the development, manufacturing and
sales of our first pharmaceutical product for PTSD”.
Liberty
Health Sciences Inc. (CSE:
LHS)
(OTCQX:
LHSIF), a provider of high quality cannabis, announced
today that it has entered into a licensing agreement with
licensed California adult use and medicinal cannabis company HONEY®, one of
California's largest full service companies, to supply all of Liberty's
dispensaries with the company's full assortment of branded products.
In 2012 HONEY® revolutionized the
cannabis industry by becoming the first producer in the world to market
distilled cannabis oil in vape cartridges. Today, they provide authentic, full
spectrum oil in vape cartridges, applicators, and caps to legal dispensaries
and delivery services.
"We are excited to partner with
HONEY®, a longstanding pioneer and premium brand in the cannabis space,"
said Victor Mancebo, Chief Executive Officer of Liberty. "Adding HONEY® to
our portfolio of brands creates an immediate distinction between other
competitors in the space and reinforces our product offering strategy to provide
variety, quality, and price versatility in all of the products we market."
All THC and CBD oil in HONEY
cartridges are free of fillers and are lab tested to be 75% +/- cannabinoids.
The devices provide the full range of benefits and deliver the precise dosage
of cannabinoids with every use.
"We are
very excited to be partnering with Liberty to introduce our HONEY® products to
the Florida medicinal cannabis market as we started in the California medical
market nearly a decade ago," said Peter Tejera, Chief Executive Officer of
HONEY®. "We look forward to growing
our in-dispensary presence in Florida and this partnership will provide
Floridian consumers with a superior choice of high quality, predictable, and consistent
product experience second to none."
THC
BioMed Intl Ltd. (CSE:
THC)
announced that
its ready-to-drink cannabis beverage shot, THC Kiss, was launched last week on
the bccannabis store website and sold out within hours. THC's fulfillment
department is now preparing its second order to B.C.
"We are very happy with the launch
of THC Kiss so far and excited to offer Canadians a true alternative to smoking
cannabis," commented John Miller, President and CEO of THC BioMed.
Each 30ml bottle of THC Kiss
contains 10 mg of THC.
The Company also announced that it
has entered into a reseller agreement whereby National Cannabis Distribution
will buy and resell cannabis products from the Company as one of two exclusive
resellers of the Company's products in Saskatchewan.
The term of the Agreement is one
year and will automatically renew unless terminated in accordance with the
Agreement.
"National Cannabis Distribution
has impressed us with its distribution network and business methods. We
appreciate that it recognizes the quality and uniqueness of our products and
has selected us as a supplier," said Mr. Miller.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
Subscribe to:
Posts (Atom)
Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX most active traders list">
Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX...
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...